A Phase II Study of SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx
Latest Information Update: 19 Mar 2024
At a glance
- Drugs Sintilimab (Primary) ; Cisplatin; Docetaxel
- Indications Carcinoma; Mouth neoplasm; Oropharyngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 19 Mar 2024 New trial record